These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6113794)

  • 1. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.
    Williams A; Gyasi H; Melloni C; Bevan DR
    Can Anaesth Soc J; 1982 Nov; 29(6):567-72. PubMed ID: 6128068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.
    Fisher DM; Miller RD
    Anesthesiology; 1983 Jun; 58(6):519-23. PubMed ID: 6134483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of halothane and enflurane on the reversibility of an Org NC45 neuromuscular blockade in cats.
    Booij LH; Crul JF; van der Pol F
    Anasth Intensivther Notfallmed; 1982 Apr; 17(2):78-80. PubMed ID: 6124173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies on Org NC 45: comparison with pancuronium.
    Kerr WJ; Baird WL
    Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intubating conditions with ORG NC45. A preliminary study.
    Harrison P; Feldman SA
    Anaesthesia; 1981 Sep; 36(9):874-7. PubMed ID: 6118074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset time and duration of action for atracurium, Org NC45 and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1982 Aug; 54(8):827-30. PubMed ID: 6125161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Org-NC45: a new steroidal non-depolarizing muscle relaxant.
    Booij LH; Vree TB; Crul JE
    Pharm Weekbl Sci; 1982 Feb; 4(1):1-4. PubMed ID: 6122196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.
    Krieg N; Mazur L; Booij LH; Crul JF
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):423-5. PubMed ID: 6110303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium.
    Son SL; Waud BE; Waud DR
    Anesthesiology; 1981 Jul; 55(1):12-8. PubMed ID: 6113793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate and blood pressure changes after ORG NC45 (vecuronium) and pancuronium during halothane and enflurane anesthesia.
    Gregoretti SM; Sohn YJ; Sia RL
    Anesthesiology; 1982 May; 56(5):392-5. PubMed ID: 6122389
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat.
    Marshall IG; Gibb AJ; Durant NN
    Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques.
    Fisher DM; Fahey MR; Cronnelly R; Miller RD
    Anesthesiology; 1982 Oct; 57(4):309-10. PubMed ID: 6127044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ORG NC45 for short intra-abdominal operations: a comparison with succinylcholine.
    Gyasi H; Williams A; Melloni C; Beran DR
    Can Anaesth Soc J; 1983 Mar; 30(2):132-5. PubMed ID: 6131736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
    Gencarelli PJ; Miller RD
    Br J Anaesth; 1982 Jan; 54(1):53-6. PubMed ID: 6119998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable muscle relaxation during abdominal surgery using combined intravenous bolus and demand infusion: clinical appraisal with ORG NC45.
    d'Hollander AA; Czerucki R; Deville A; Cuvelier F
    Can Anaesth Soc J; 1982 Mar; 29(2):136-41. PubMed ID: 6121614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
    Fahey MR; Morris RB; Miller RD; Nguyen TL; Upton RA
    Br J Anaesth; 1981 Oct; 53(10):1049-53. PubMed ID: 6117300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hypercarbia and hypocarbia on pancuronium and vecuronium neuromuscular blockades in anesthetized humans.
    Gencarelli PJ; Swen J; Koot HW; Miller RD
    Anesthesiology; 1983 Nov; 59(5):376-80. PubMed ID: 6139044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.